TWIN DISC INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that TWIN DISC INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $340.74M | Sep 5, 2025 |
| FY2025 | Jun 30, 2024 | $295.13M | Sep 5, 2025 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Jun 30, 2017 | $168.18M | Aug 31, 2017 |
| FY2016 | Jun 30, 2016 | $166.28M | Sep 13, 2016 |
| FY2015 | Jun 30, 2015 | $265.79M | Sep 14, 2015 |
| FY2014 | Jun 30, 2014 | $263.91M | Sep 15, 2014 |
| FY2013 | Jun 30, 2013 | $285.28M | Sep 13, 2013 |
| FY2012 | Jun 30, 2012 | $355.87M | Oct 9, 2012 |
| FY2012 | Jun 30, 2011 | $310.39M | Oct 9, 2012 |
| FY2012 | Jun 30, 2010 | $227.53M | Oct 9, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $92.73M | Sep 5, 2025 |
| FY2025 | Jun 30, 2024 | $83.32M | Sep 5, 2025 |
| FY2024 | Jun 30, 2023 | $74.33M | Sep 6, 2024 |
| FY2023 | Jun 30, 2022 | $68.81M | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | $50.86M | Sep 8, 2022 |
| FY2021 | Jun 30, 2020 | $55.71M | Sep 2, 2021 |
| FY2020 | Jun 30, 2019 | $89.64M | Aug 26, 2020 |
| FY2019 | Jun 30, 2018 | $80.64M | Aug 29, 2019 |
| FY2018 | Jun 30, 2017 | $48.23M | Aug 27, 2018 |
| FY2018 | Jun 30, 2016 | $40.60M | Aug 27, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($1.89M) | Sep 5, 2025 |
| FY2025 | Jun 30, 2024 | $10.99M | Sep 5, 2025 |
| FY2024 | Jun 30, 2023 | $10.38M | Sep 6, 2024 |
| FY2023 | Jun 30, 2022 | $10.47M | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | ($29.72M) | Sep 8, 2022 |
| FY2021 | Jun 30, 2020 | ($39.82M) | Sep 2, 2021 |
| FY2020 | Jun 30, 2019 | $10.67M | Aug 26, 2020 |
| FY2019 | Jun 30, 2018 | $9.53M | Aug 29, 2019 |
| FY2018 | Jun 30, 2017 | ($6.29M) | Aug 27, 2018 |
| FY2018 | Jun 30, 2016 | ($13.10M) | Aug 27, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $9.89M | Sep 5, 2025 |
| FY2025 | Jun 30, 2024 | $11.48M | Sep 5, 2025 |
| FY2024 | Jun 30, 2023 | $16.06M | Sep 6, 2024 |
| FY2023 | Jun 30, 2022 | $11.04M | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | ($12.27M) | Sep 8, 2022 |
| FY2021 | Jun 30, 2020 | ($40.25M) | Sep 2, 2021 |
| FY2020 | Jun 30, 2019 | $18.50M | Aug 26, 2020 |
| FY2019 | Jun 30, 2018 | $16.15M | Aug 29, 2019 |
| FY2018 | Jun 30, 2017 | ($8.98M) | Aug 27, 2018 |
| FY2018 | Jun 30, 2016 | ($24.60M) | Aug 27, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $2.70M | Sep 5, 2025 |
| FY2025 | Jun 30, 2024 | $2.63M | Sep 5, 2025 |
| FY2024 | Jun 30, 2023 | $2.46M | Sep 6, 2024 |
| FY2023 | Jun 30, 2022 | $1.58M | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | $1.87M | Sep 8, 2022 |
| FY2021 | Jun 30, 2020 | $1.82M | Sep 2, 2021 |
| FY2020 | Jun 30, 2019 | $2.39M | Aug 26, 2020 |
| FY2019 | Jun 30, 2018 | $1.61M | Aug 29, 2019 |
| FY2018 | Jun 30, 2017 | $1.55M | Aug 27, 2018 |
| FY2018 | Jun 30, 2016 | $1.81M | Aug 27, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $82.43M | Sep 5, 2025 |
| FY2025 | Jun 30, 2024 | $71.62M | Sep 5, 2025 |
| FY2024 | Jun 30, 2023 | $62.24M | Sep 6, 2024 |
| FY2023 | Jun 30, 2022 | $60.09M | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | $55.75M | Sep 8, 2022 |
| FY2021 | Jun 30, 2020 | $63.22M | Sep 2, 2021 |
| FY2020 | Jun 30, 2019 | $71.54M | Aug 26, 2020 |
| FY2019 | Jun 30, 2018 | $61.10M | Aug 29, 2019 |
| FY2018 | Jun 30, 2017 | $52.77M | Aug 27, 2018 |
| FY2018 | Jun 30, 2016 | $57.11M | Aug 27, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $23.98M | Sep 5, 2025 |
| FY2025 | Jun 30, 2024 | $33.72M | Sep 5, 2025 |
| FY2024 | Jun 30, 2023 | $22.90M | Sep 6, 2024 |
| FY2023 | Jun 30, 2022 | ($8.31M) | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | $6.53M | Sep 8, 2022 |
| FY2021 | Jun 30, 2020 | $9.12M | Sep 2, 2021 |
| FY2020 | Jun 30, 2019 | ($5.46M) | Aug 26, 2020 |
| FY2019 | Jun 30, 2018 | $6.51M | Aug 29, 2019 |
| FY2018 | Jun 30, 2017 | $3.18M | Aug 27, 2018 |
| FY2018 | Jun 30, 2016 | $3.39M | Aug 27, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $15.16M | Sep 5, 2025 |
| FY2025 | Jun 30, 2024 | $8.71M | Sep 5, 2025 |
| FY2024 | Jun 30, 2023 | $7.92M | Sep 6, 2024 |
| FY2023 | Jun 30, 2022 | $4.73M | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | $4.46M | Sep 8, 2022 |
| FY2021 | Jun 30, 2020 | $10.70M | Sep 2, 2021 |
| FY2020 | Jun 30, 2019 | $11.98M | Aug 26, 2020 |
| FY2019 | Jun 30, 2018 | $6.33M | Aug 29, 2019 |
| FY2018 | Jun 30, 2017 | $3.13M | Aug 27, 2018 |
| FY2018 | Jun 30, 2016 | $4.21M | Aug 27, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $355.56M | Sep 5, 2025 |
| FY2025 | Jun 30, 2024 | $312.06M | Sep 5, 2025 |
| FY2024 | Jun 30, 2023 | $289.18M | Sep 6, 2024 |
| FY2023 | Jun 30, 2022 | $276.52M | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | $275.41M | Sep 8, 2022 |
| FY2021 | Jun 30, 2020 | $294.13M | Sep 2, 2021 |
| FY2020 | Jun 30, 2019 | $346.87M | Aug 26, 2020 |
| FY2019 | Jun 30, 2018 | $241.24M | Aug 29, 2019 |
| FY2018 | Jun 30, 2017 | $210.90M | Aug 27, 2018 |
| FY2018 | Jun 30, 2016 | $213.92M | Aug 27, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $191.17M | Sep 5, 2025 |
| FY2025 | Jun 30, 2024 | $157.00M | Sep 5, 2025 |
| FY2024 | Jun 30, 2023 | $143.66M | Sep 6, 2024 |
| FY2023 | Jun 30, 2022 | $145.34M | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | $144.75M | Sep 8, 2022 |
| FY2021 | Jun 30, 2020 | $154.17M | Sep 2, 2021 |
| FY2020 | Jun 30, 2019 | $164.05M | Aug 26, 2020 |
| FY2019 | Jun 30, 2018 | $97.62M | Aug 29, 2019 |
| FY2018 | Jun 30, 2017 | $87.33M | Aug 27, 2018 |
| FY2017 | Jun 30, 2016 | $96.87M | Aug 31, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $164.01M | Sep 5, 2025 |
| FY2025 | Jun 30, 2024 | $154.70M | Sep 5, 2025 |
| FY2024 | Jun 30, 2023 | $145.09M | Sep 6, 2024 |
| FY2023 | Jun 30, 2022 | $130.78M | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | $130.21M | Sep 8, 2022 |
| FY2021 | Jun 30, 2020 | $139.39M | Sep 2, 2021 |
| FY2020 | Jun 30, 2019 | $182.22M | Aug 26, 2020 |
| FY2019 | Jun 30, 2018 | $143.00M | Aug 29, 2019 |
| FY2018 | Jun 30, 2017 | $122.92M | Aug 27, 2018 |
| FY2017 | Jun 30, 2016 | $116.49M | Aug 31, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $2.89M | Sep 5, 2025 |
| FY2025 | Jun 30, 2024 | $0 | Sep 5, 2025 |
| FY2023 | Jun 30, 2023 | $0 | Sep 8, 2023 |
| FY2023 | Jun 30, 2022 | $0 | Sep 8, 2023 |
| FY2023 | Jun 30, 2021 | $0 | Sep 8, 2023 |
| FY2022 | Jun 30, 2020 | $0 | Sep 8, 2022 |
| FY2021 | Mar 27, 2020 | $25.38M | Sep 2, 2021 |
| FY2021 | Jun 30, 2019 | $25.95M | Sep 2, 2021 |
| FY2020 | Jun 30, 2018 | $2.69M | Aug 26, 2020 |
| FY2019 | Jun 30, 2017 | $2.59M | Aug 29, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $125.41M | Sep 5, 2025 |
| FY2025 | Jun 30, 2024 | $129.59M | Sep 5, 2025 |
| FY2024 | Jun 30, 2023 | $120.30M | Sep 6, 2024 |
| FY2023 | Jun 30, 2022 | $109.92M | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | $126.94M | Sep 8, 2022 |
| FY2021 | Jun 30, 2020 | $156.66M | Sep 2, 2021 |
| FY2020 | Jun 30, 2019 | $196.47M | Aug 26, 2020 |
| FY2019 | Jun 30, 2018 | $178.90M | Aug 29, 2019 |
| FY2018 | Jun 30, 2017 | $169.37M | Aug 27, 2018 |
| FY2017 | Jun 30, 2016 | $175.66M | Aug 31, 2017 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $31.45M | Sep 5, 2025 |
| FY2025 | Jun 30, 2024 | $25.81M | Sep 5, 2025 |
| FY2024 | Jun 30, 2023 | $18.63M | Sep 6, 2024 |
| FY2023 | Jun 30, 2022 | $36.54M | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | $32.09M | Sep 8, 2022 |
| FY2021 | Jun 30, 2020 | $42.59M | Sep 2, 2021 |
| FY2020 | Jun 30, 2019 | $42.49M | Aug 26, 2020 |
| FY2019 | Jun 30, 2018 | $4.82M | Aug 29, 2019 |
| FY2018 | Jun 30, 2017 | $6.32M | Aug 27, 2018 |
| FY2017 | Jun 30, 2016 | $8.50M | Aug 31, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Sep 5, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Sep 5, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Sep 6, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | (2) | Sep 8, 2022 |
| FY2021 | Jun 30, 2020 | (3) | Sep 2, 2021 |
| FY2020 | Jun 30, 2019 | 0 | Aug 26, 2020 |
| FY2019 | Jun 30, 2018 | 0 | Aug 29, 2019 |
| FY2018 | Jun 30, 2017 | 0 | Aug 27, 2018 |
| FY2018 | Jun 30, 2016 | (1) | Aug 27, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Sep 5, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Sep 5, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Sep 6, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | (2) | Sep 8, 2022 |
| FY2021 | Jun 30, 2020 | (3) | Sep 2, 2021 |
| FY2020 | Jun 30, 2019 | 0 | Aug 26, 2020 |
| FY2019 | Jun 30, 2018 | 0 | Aug 29, 2019 |
| FY2018 | Jun 30, 2017 | 0 | Aug 27, 2018 |
| FY2018 | Jun 30, 2016 | (1) | Aug 27, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 14.15M | Sep 5, 2025 |
| FY2025 | Jun 30, 2024 | 14.00M | Sep 5, 2025 |
| FY2024 | Jun 30, 2023 | 13.82M | Sep 6, 2024 |
| FY2023 | Jun 30, 2022 | 13.67M | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | 13.65M | Sep 8, 2022 |
| FY2021 | Jun 30, 2020 | 13.41M | Sep 2, 2021 |
| FY2020 | Jun 30, 2019 | 13.24M | Aug 26, 2020 |
| FY2019 | Jun 30, 2018 | 11.55M | Aug 29, 2019 |
| FY2018 | Jun 30, 2017 | 11.52M | Aug 27, 2018 |
| FY2018 | Jun 30, 2016 | 11.35M | Aug 27, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $2.28M | Sep 5, 2025 |
| FY2025 | Jun 30, 2024 | $1.70M | Sep 5, 2025 |
| FY2024 | Jun 30, 2023 | $0 | Sep 6, 2024 |
| FY2018 | Jun 30, 2016 | $2.04M | Aug 27, 2018 |
| FY2017 | Jun 30, 2015 | $4.06M | Aug 31, 2017 |
| FY2016 | Jun 30, 2014 | $4.06M | Sep 13, 2016 |
| FY2015 | Jun 30, 2013 | $4.08M | Sep 14, 2015 |
| FY2014 | Jun 30, 2012 | $3.89M | Sep 15, 2014 |
| FY2013 | Jun 30, 2011 | $3.41M | Sep 13, 2013 |
| FY2012 | Jun 30, 2010 | $3.13M | Oct 9, 2012 |